IRadimed Corporation
IRMD
$51.32
-$0.96-1.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.87% | 11.10% | 11.04% | 11.15% | 13.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.87% | 11.10% | 11.04% | 11.15% | 13.72% |
| Cost of Revenue | 10.86% | 14.58% | 12.73% | -0.62% | 12.17% |
| Gross Profit | 10.87% | 10.05% | 10.55% | 14.96% | 14.22% |
| SG&A Expenses | 12.38% | 10.35% | 19.79% | 21.05% | 12.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.57% | 10.55% | 18.28% | 10.16% | 12.05% |
| Operating Income | 14.39% | 12.41% | -1.97% | 13.38% | 18.49% |
| Income Before Tax | 13.39% | 11.67% | 0.15% | 18.32% | 20.55% |
| Income Tax Expenses | 13.64% | 4.87% | 2.04% | 22.30% | 17.32% |
| Earnings from Continuing Operations | 13.32% | 13.37% | -0.35% | 17.26% | 21.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.32% | 13.37% | -0.35% | 17.26% | 21.44% |
| EBIT | 14.39% | 12.41% | -1.97% | 13.38% | 18.49% |
| EBITDA | 13.09% | 11.74% | -1.78% | 13.12% | 18.73% |
| EPS Basic | 12.86% | 12.82% | -0.90% | 16.64% | 20.78% |
| Normalized Basic EPS | 12.94% | 10.92% | -0.38% | 17.69% | 19.87% |
| EPS Diluted | 15.22% | 11.48% | -0.38% | 15.15% | 18.52% |
| Normalized Diluted EPS | 12.72% | 10.84% | -0.19% | 17.98% | 19.93% |
| Average Basic Shares Outstanding | 0.41% | 0.50% | 0.53% | 0.55% | 0.55% |
| Average Diluted Shares Outstanding | 0.59% | 0.56% | 0.33% | 0.28% | 0.50% |
| Dividend Per Share | -- | 13.33% | -- | -- | -- |
| Payout Ratio | -0.76% | -- | -- | -- | -0.50% |